XML 12 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 2,972,051 $ 4,084,085
Grants receivable 0 757,562
Prepaid expenses 276,714 419,751
Other current assets 3,965 47,586
Total current assets 3,252,730 5,308,984
Property and equipment, net 515,522 135,486
Goodwill 6,826,003 6,826,003
Other long term assets 346,233 126,654
Total assets 10,940,488 12,397,127
Current liabilities:    
Accounts payable 2,161,127 3,002,497
Accrued compensation 482,528 562,755
Accrued clinical operations and site costs 491,157 391,041
Accrued lease contingency fee 590,504 590,504
License fee payable 225,000 225,000
Other accrued expenses 412,373 186,566
Interest payable 50,500 0
Current portion of notes payable (694,444) 0
Current portion of capital leases payable 16,303 0
Total current liabilities 5,123,936 4,958,363
Long-term liabilities:    
Long-term portion of notes payable, net 4,087,760 0
Long-term portion of capital leases 76,799 0
Other long-term liabilities 115,452 0
Total long-term liabilities 3,585,567 0
Commitments and contingencies:  
Stockholders' equity:    
Common stock, $0.01 par value; 150,000,000 shares authorized, 29,311,272 and 28,391,072 shares issued and outstanding as of March 31, 2016 and December 31, 2015, respectively 307,878 283,911
Additional paid-in capital 70,715,564 67,754,383
Accumulated deficit (68,794,523) (60,601,778)
Total stockholders' equity 2,230,985 7,438,764
Total liabilities and stockholders' equity 10,940,488 12,397,127
Series D Convertible Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock $ 1,733 1,915
Series E Convertible Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock   $ 333